Literature DB >> 18263715

A positive inotropic effect of ATP in the human cardiac atrium.

Ulrich Gergs1, Peter Boknik, Wilhelm Schmitz, Andreas Simm, Rolf-Edgar Silber, Joachim Neumann.   

Abstract

We studied contractile effects in isolated electrically driven (1 Hz) atrial preparations from patients undergoing cardiac bypass surgery. ATP concentration dependently (10, 30, and 100 microM) and rapidly decreased force of contraction (negative inotropic effect, NIE) and thereafter more slowly increased force of contraction. The maximum positive inotropic effect (PIE) at 100 microM ATP amounted to 152% of the predrug value (n = 9) and was stable and could be washed out fast and completely. The PIE did not affect time parameters of contraction (time to peak tension and time of relaxation). Moreover, a similar NIE and PIE were noted with adenosine 5'-O-(2-thiotriphosphate) (100 microM). In contrast 2-methyl-thio-ATP did not exert a NIE but only a PIE. In a second set of experiments, preparations were first incubated for 30 min with purinoreceptor antagonists and, in their continuous presence, 100 microM ATP was applied. However, the PIE and NIE of ATP could neither be blocked with suramin (100 and 500 microM), pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (50 microM), nor reactive blue 2 (30, 100, and 500 microM), which are known blockers for subtypes of P(2) receptors, or 1,3-dipropyl-cyclopentvl-xanthine (1 and 10 microM), a subtype (A(1) adenosine) P(1) receptor blocker. Likewise, the inhibitor of phospholipase C (PLC) activity (U-73122) and the inhibitor of adenylate cyclase activity (SQ-022563) (10 microM each) failed to affect the NIE and the PIE of ATP. We tentatively suggest that the PIE of ATP might be mediated via P(2X4)-like receptors. In summary, we describe a novel biphasic effect of ATP on force contraction in the isolated human atrium. It is conceivable that ATP plays a physiological role in the human heart, for instance, after cardiac injury to sustain contractility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263715     DOI: 10.1152/ajpheart.00945.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  P2 purinergic receptor mRNA in rat and human sinoatrial node and other heart regions.

Authors:  Hanny Musa; James O Tellez; Natalie J Chandler; Ian D Greener; Michał Maczewski; Urszula Mackiewicz; Andrzej Beresewicz; Peter Molenaar; Mark R Boyett; Halina Dobrzynski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-21       Impact factor: 3.000

3.  The therapeutic effect of 2-cyclohexylthio-AMP in heart failure.

Authors:  Siyuan Zhou; Tiehong Yang; Kenneth A Jacobson; Bruce T Liang
Journal:  J Cardiovasc Pharmacol       Date:  2013-06       Impact factor: 3.105

4.  Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.

Authors:  Sergio Signore; Andrea Sorrentino; João Ferreira-Martins; Ramaswamy Kannappan; Mehrdad Shafaie; Fabio Del Ben; Kazuya Isobe; Christian Arranto; Ewa Wybieralska; Andrew Webster; Fumihiro Sanada; Barbara Ogórek; Hanqiao Zheng; Xiaoxia Liu; Federica Del Monte; David A D'Alessandro; Oriyanhan Wunimenghe; Robert E Michler; Toru Hosoda; Polina Goichberg; Annarosa Leri; Jan Kajstura; Piero Anversa; Marcello Rota
Journal:  Circulation       Date:  2013-08-27       Impact factor: 29.690

5.  A positive inotropic effect of adenosine in cardiac preparations of right atria from diseased human hearts.

Authors:  Ulrich Gergs; Peter Boknik; Wilhelm Schmitz; Andreas Simm; Rolf-Edgar Silber; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-27       Impact factor: 3.000

6.  Novel protective role of endogenous cardiac myocyte P2X4 receptors in heart failure.

Authors:  Tiehong Yang; Jian-bing Shen; Ronghua Yang; John Redden; Kimberly Dodge-Kafka; James Grady; Kenneth A Jacobson; Bruce T Liang
Journal:  Circ Heart Fail       Date:  2014-03-12       Impact factor: 8.790

7.  Role of P2X purinergic receptors in the rescue of ischemic heart failure.

Authors:  Dmitry Sonin; Si-Yuan Zhou; Chunxia Cronin; Tatiana Sonina; Jeffrey Wu; Kenneth A Jacobson; Achilles Pappano; Bruce T Liang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-18       Impact factor: 4.733

8.  Increased Gi protein signaling potentiates the negative chronotropic effect of adenosine in the SHR right atrium.

Authors:  Juliano Q D Rodrigues; Henrique Camara; Aron Jurkiewicz; Rosely O Godinho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-22       Impact factor: 3.000

9.  The Ionotropic P2X4 Receptor has Unique Properties in the Heart by Mediating the Negative Chronotropic Effect of ATP While Increasing the Ventricular Inotropy.

Authors:  Bruno Bragança; Sílvia Nogueira-Marques; Fátima Ferreirinha; Ana Patrícia Fontes-Sousa; Paulo Correia-de-Sá
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

10.  Adenosine-5'-triphosphate (ATP) supplementation improves low peak muscle torque and torque fatigue during repeated high intensity exercise sets.

Authors:  John A Rathmacher; John C Fuller; Shawn M Baier; Naji N Abumrad; Hector F Angus; Rick L Sharp
Journal:  J Int Soc Sports Nutr       Date:  2012-10-09       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.